This country profile provides an overview of Chad’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
71%
Blinding trachoma
57%
Intestinal worms
62%
Bilharzia
66%
River blindness
70%
4.34 million
people received treatment in Chad in 2019
1.93 million
people did not receive treatment in Chad in 2019
Elephantiasis
Treatment coverage decreased from 75% in 2018 to 71% in 2019.
People needing treatment
5.12m
People receiving treatment
3.65m
Blinding trachoma
Treatment coverage increased from 51% in 2018 to 57% in 2019.
People needing treatment
3.49m
People receiving treatment
1.97m
Intestinal worms
Treatment coverage increased from 60% in 2018 to 62% in 2019.
Pre-sch and school-aged children needing treatment
545k
Pre-school and school-aged children receiving treatment
337k
Bilharzia
Treatment coverage decreased from 71% in 2018 to 66% in 2019.
School-aged children needing treatment
2.33m
School-aged children receiving treatment
1.54m
River blindness
Treatment coverage decreased from 72% in 2018 to 70% in 2019.
People needing treatment
5.79m
People receiving treatment
4.06m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Chad.